Usage Information

Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
G Morstyn, S M Hsu, T Kinsella, H Gratzner, A Russo, J B Mitchell
G Morstyn, S M Hsu, T Kinsella, H Gratzner, A Russo, J B Mitchell
View: Text | PDF
Research Article

Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.

Abstract

Using a monoclonal antibody to bromodeoxyuridine (BUdR) and immunohistochemistry, we measured the incorporation of this thymidine analogue into the DNA of human normal and malignant cells exposed in vivo. BUdR given as a constant intravenous infusion for 12 or 24 h daily for up to 13 d resulted in a steady-state plasma level of 10(-6) M during the infusion. We demonstrated extensive incorporation of BUdR into both normal skin, normal bone marrow, and malignant melanoma cells. In addition, this infusion of BUdR was adequate to identify sister chromatid exchanges from human marrow chromosomes exposed in vivo. Using this constant infusion, significant but reversible (acute) toxicity was observed with myelosuppression and skin photosensitivity. These techniques, which are considerably less cumbersome and time-consuming than the use of radioactive isotopes of thymidine, can be used for further human studies of cell kinetics and chromosomal replication in both normal and malignant cells.

Authors

G Morstyn, S M Hsu, T Kinsella, H Gratzner, A Russo, J B Mitchell

×

Usage data is cumulative from July 2025 through July 2026.

Usage JCI PMC
Text version 374 9
PDF 170 14
Figure 0 2
Scanned page 558 1
Citation downloads 175 0
Totals 1,277 26
Total Views 1,303
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement